glp 1 review GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Frontiers | Exploring the multifaceted
Description
Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients
I also discontinued medications such as Losartan and certain others after experiencing side effects, while focusing on improving recovery conditions and minimizing environmental and physiological triggers that were affecting my health.
Garczorz W, Gallego-Colon E, Kosowska A, Kych-Ratuszny A, Woniak M, Marcol W, Niesner KJ, Francuz T
Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study
